Zevra Therapeutics Q2 2025 Earnings Preview

2 hours ago 1

Zevra Therapeutics (NASDAQ:ZVRA) is scheduled to announce Q2 earnings results on Tuesday, August 12th, after market close.
The consensus EPS Estimate is $1.38 and the consensus Revenue Estimate is $22.49M (-94.9% Y/Y).
Over the last 1 year, ZVRA has beaten

Recommended For You